These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31865778)

  • 1. Exploring 2D-QSAR for prediction of beta-secretase 1 (BACE1) inhibitory activity against Alzheimer's disease.
    Kumar V; Ojha PK; Saha A; Roy K
    SAR QSAR Environ Res; 2020 Feb; 31(2):87-133. PubMed ID: 31865778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V; De P; Ojha PK; Saha A; Roy K
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach.
    Dhanabalan AK; Kesherwani M; Velmurugan D; Gunasekaran K
    J Mol Graph Model; 2017 Sep; 76():56-69. PubMed ID: 28710924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A; Roy S; Tripathi S; Sharma A
    J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cheminformatic modelling of β-amyloid aggregation inhibitory activity against Alzheimer's disease.
    Kumar V; Ojha PK; Saha A; Roy K
    Comput Biol Med; 2020 Mar; 118():103658. PubMed ID: 32174326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insights into the inhibitory mechanism of bi-functional bis-tryptoline triazole against β-secretase (BACE1) enzyme.
    Narang SS; Goyal D; Goyal B
    Amino Acids; 2019 Nov; 51(10-12):1593-1607. PubMed ID: 31654211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.
    Palakurti R; Vadrevu R
    Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction mechanism exploration of HEA derivatives as BACE1 inhibitors by in silico analysis.
    Wu Q; Li X; Gao Q; Wang J; Li Y; Yang L
    Mol Biosyst; 2016 Apr; 12(4):1151-65. PubMed ID: 26915506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-secretase inhibitors for Alzheimer's disease: identification using pharmacoinformatics.
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2019 Feb; 37(2):503-522. PubMed ID: 29388503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation.
    Das S; Majumder T; Sarkar A; Mukherjee P; Basu S
    Int J Biol Macromol; 2020 Dec; 165(Pt A):1323-1330. PubMed ID: 33010267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
    Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
    FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
    Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition.
    Chakraborty S; Ramachandran B; Basu S
    Mol Biosyst; 2014 Oct; 10(10):2684-92. PubMed ID: 25088750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACE1 Inhibition by Genistein: Biological Evaluation, Kinetic Analysis, and Molecular Docking Simulation.
    Youn K; Park JH; Lee S; Lee S; Lee J; Yun EY; Jeong WS; Jun M
    J Med Food; 2018 Apr; 21(4):416-420. PubMed ID: 29444415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.
    Dhamodharan G; Mohan CG
    Mol Divers; 2022 Jun; 26(3):1501-1517. PubMed ID: 34327619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
    Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
    Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Docking and 3D Qsar Studies of C000000956 as a Potent Inhibitor of Bace-1.
    Joseph OA; Babatomiwa K; Niyi A; Olaposi O; Olumide I
    Drug Res (Stuttg); 2019 Aug; 69(8):451-457. PubMed ID: 30780168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.